Author:
Rajender Reddy K.,Modi Marlene W.,Pedder Simon
Reference58 articles.
1. Pegylation: a novel process for modifying pharmacokinetics;Harris;Clin. Pharmacokinet.,2001
2. A branched methoxy 40 kDa polyethylene glycol (PEG) moiety optimizes the pharmacokinetics (PK) of peginterferon a-2a (PEG–IFN) and may explain its enhanced efficacy in chronic hepatitis C (CHC);Algranati;Hepatology,1999
3. Interferon kinetics and adverse reactions after intravenous, intramuscular, and subcutaneous injection;Wills;Clin. Pharmacol. Ther.,1984
4. Clinical pharmacokinetics of interferons;Wills;Clin. Pharmacokinet.,1990
5. Influence of human serum albumin content in formulations on the bioequivalency of interferon alfa-2a given by subcutaneous injection in healthy male volunteers;Zhi;J. Clin. Pharmacol,1995
Cited by
208 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献